| EZH2-H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis A Verma, A Singh, MP Singh, MA Nengroo, KK Saini, SR Satrusal, ... Nature communications 13 (1), 7344, 2022 | 41 | 2022 |
| Salinomycin inhibits epigenetic modulator EZH2 to enhance death receptors in colon cancer stem cells AK Singh, A Verma, A Singh, RK Arya, S Maheshwari, P Chaturvedi, ... Epigenetics 16 (2), 144-161, 2021 | 23 | 2021 |
| CXCR4 intracellular protein promotes drug resistance and tumorigenic potential by inversely regulating the expression of Death Receptor 5 MA Nengroo, S Maheshwari, A Singh, A Verma, RK Arya, P Chaturvedi, ... Cell Death & Disease 12 (5), 464, 2021 | 22 | 2021 |
| Cytokine chemokine network in tumor microenvironment: Impact on CSC properties and therapeutic applications MA Nengroo, A Verma, D Datta Cytokine 156, 155916, 2022 | 18 | 2022 |
| Demystifying the CXCR4 conundrum in cancer biology: Beyond the surface signaling paradigm MA Nengroo, MA Khan, A Verma, D Datta Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1877 (5), 188790, 2022 | 13 | 2022 |
| Loss of PERK function promotes ferroptosis by downregulating SLC7A11 (System Xc⁻) in colorectal cancer KK Saini, P Chaturvedi, A Sinha, MP Singh, MA Khan, A Verma, ... Redox Biology 65, 102833, 2023 | 12 | 2023 |
| Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate Cancer A Yadav, T Biswas, A Praveen, P Ganguly, A Bhattacharyya, A Verma, ... Cancer Research Communications 3 (10), 2044-2061, 2023 | 3 | 2023 |
| PERK arm of UPR selectively regulates ferroptosis in colon cancer cells by modulating the expression of system xc - (SLC7A11) KK Saini, P Chaturvedi, A Verma, MA Nengroo, A Sinha, A Singh, ... Cancer Research 82 (12_Supplement), 6249-6249, 2022 | 2 | 2022 |
| Epigenetic modulator EZH2 governs CSC properties and alters metastatic cascade A Verma, A Singh, AK Singh, P Chaturvedi, MA Nengroo, D Datta Cancer Medicine 7, 30-30, 2018 | 2 | 2018 |
| H3K27me3 mediated KRT14 upregulation promotes TNBC peritoneal metastasis A Verma, A Singh, MA Nengroo, KK Saini, A Sinha, AK Singh, D Datta bioRxiv, 2021.02. 02.429349, 2021 | 1 | 2021 |
| Selective ezh2 functional activation alters the metastatic landscape of triple negative breast cancer A Verma, A Singh, AK Singh, P Chaturvedi, MA Nengroo, K Saini, ... Cancer Research 80 (16_Supplement), 3837-3837, 2020 | 1 | 2020 |
| Experimental type 1 diabetes metabolically rejuvenates CD8+ T cells for improved control of tumor growth through an IGF1-IGF1R axis A Sarkar, S Dhar, S Bera, M Chakravarti, A Verma, P Prasad, J Sultana, ... bioRxiv, 2024.04. 04.588206, 2024 | | 2024 |
| ACSL4 activity drives TNBC metastasis by positively regulating Histone H3 Acetylation mediated SNAIL expression A Sinha, KK Saini, K Tripathi, MA Khan, SR Satrusal, A Verma, B Mandal, ... bioRxiv, 2023.10. 16.562466, 2023 | | 2023 |
| PERK arm of UPR selectively regulates ferroptosis in colon cancer cells by modulating the expression of SLC7A11 (System Xc-) KK Saini, P Chaturvedi, A Sinha, MP Singh, MA Khan, A Verma, ... bioRxiv, 2023.03. 28.534659, 2023 | | 2023 |
| Modulation of DNA/RNA Methylation by Small-Molecule Modulators and Their Implications in Cancer A Verma, A Sinha, D Datta Metabolism and Epigenetic Regulation: Implications in Cancer, 557-579, 2022 | | 2022 |
| CXCR4 intracellular protein regulates chemotherapy resistance by modulating the expression of death receptor 5 MA Nengroo, S Maheshwari, A Singh, AK Singh, P Chaturvedi, A Verma, ... Cancer Research 80 (16_Supplement), 6325-6325, 2020 | | 2020 |
| CXCR4 intracellular protein regulates drug resistance and tumorigenic potential via modulating the expression of Death Receptor 5 MA Nengroo, S Maheshwari, A Singh, AK Singh, RK Arya, P Chaturvedi, ... bioRxiv, 843995, 2019 | | 2019 |
| Chemokine receptor CXCR4 but not CXCR7 promotes drug resistance in cancer via death receptor downregulation S Maheshwari, MA Nengroo, A Singh, P Chaturvedi, A Verma, D Datta CANCER MEDICINE 7, 40-40, 2018 | | 2018 |
Dipak DattaProfessor, Senior Principal Scientist, CSIR-Central Drug Research Institute在 cdri.res.in 的电子邮件经过验证
